Combined intravenous and intra-arterial approach in acute stroke treatment

Bibliography

• SUSSMAN BJ, FITCH TS: Thrombolysis with fibrinolysin in cerebral arterial occlusion. J. Am. Med. Assoc. (1958) 167(14):1705-1709.
   PubMed Web of Science ®Google Scholar
• MEYER JS, GILROY J, BARNHART MI, JOHNSON JF: Therapeutic thrombolysis in carotid and middle cerebral arterial occlusion. Neurology (1963) 13:927-937.
   PubMed Web of Science ®Google Scholar
• Tissue plasminogen activator for acute ischaemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. (1995) 333(24):1581-1587.
   PubMed Web of Science ®Google Scholar
• HILL MD, BUCHAN AM: Thrombolysis for acute ischaemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ (2005) 172(10):1307-1312.
   PubMed Web of Science ®Google Scholar
• WAHLGREN N, AHMED N, DAVALOS A et al.: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 369(9558):275-282.
   PubMed Web of Science ®Google Scholar
• HACKE W, DONNAN G, FIESCHI C et al.: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 363(9411):768-774.
   PubMed Web of Science ®Google Scholar
• MARLER JR, TILLEY BC, LU M et al.: Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 55(11):1649-1655.
   PubMed Web of Science ®Google Scholar
• LEWANDOWSKI CA, FRANKEL M, TOMSICK TA et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischaemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 30(12):2598-2605.
   PubMed Web of Science ®Google Scholar
• JUNGREIS CA, WECHSLER LR, HORTON JA: Intracranial thrombolysis via a catheter embedded in the clot. Stroke (1989) 20(11):1578-1580.
   PubMed Web of Science ®Google Scholar
• NESBIT GM, CLARK WM, O'NEILL OR, BARNWELL SL: Intracranial intraarterial thrombolysis facilitated by microcatheter navigation through an occluded cervical internal carotid artery. J. Neurosurg. (1996) 84(3):387-392.
   PubMed Web of Science ®Google Scholar
• CASTO L, CAVERNI L, CAMERLINGO M et al.: Intra-arterial thrombolysis in acute ischaemic stroke: experience with a superselective catheter embedded in the clot. J. Neurol. Neurosurg. Psychiatry (1996) 60(6):667-670.
   PubMed Web of Science ®Google Scholar
• QURESHI AI, ALI Z, SURI MF et al.: Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischaemic stroke. Neurosurgery (2001) 49(1):41-48; discussion 48-50.
   PubMed Web of Science ®Google Scholar
• HILL MD, BARBER PA, DEMCHUK AM et al.: Acute intravenous–intra-arterial revascularization therapy for severe ischaemic stroke. Stroke (2002) 33(1):279-282.
   PubMed Web of Science ®Google Scholar
• POLOSIN K, BURTSEV EM: A case of the successful use of regional thrombolytic therapy in acute ischaemic stroke. Zh Nevropatol Psikhiatr Im S S Korsakova (1994) 94(1):85-87.
   Google Scholar
• KIM YS, GARAMI Z, MIKULIK R, MOLINA CA, ALEXANDROV AV: Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke (2005) 36(4):869-871.
   PubMed Web of Science ®Google Scholar
• Combined intravenous and intra-arterial recanalization for acute ischaemic stroke: the Interventional Management of Stroke Study. Stroke (2004) 35(4):904-911.
   PubMed Web of Science ®Google Scholar
• LEE KY, HAN SW, KIM SH et al.: Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischaemic stroke patients. Stroke (2007) 38(1):192-193.
   PubMed Web of Science ®Google Scholar
• JANSEN O, VON KUMMER R, FORSTING M, HACKE W, SARTOR K: Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am. J. Neuroradiol. (1995) 16(10):1977-1986.
   PubMed Web of Science ®Google Scholar
• BRANDT T, VON KUMMER R, MULLER-KUPPERS M, HACKE W: Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke (1996) 27(5):875-881.
   PubMed Web of Science ®Google Scholar
• Intraarterial thrombolysis: ready for prime time? Executive Committee of the ASITN. American Society of Interventional and Therapeutic Neuroradiology. AJNR Am. J. Neuroradiol. (2001) 22(1):55-58.
   PubMed Web of Science ®Google Scholar
• Intracerebral haemorrhage after intravenous t-PA therapy for ischaemic stroke. The NINDS t-PA Stroke Study Group. Stroke (1997) 28(11):2109-2118.
   PubMed Web of Science ®Google Scholar
• ALEXANDROV AV, GROTTA JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology (2002) 59(6):862-867.
   PubMed Web of Science ®Google Scholar
• RUBIERA M, ALVAREZ-SABIN J, RIBO M et al.: Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischaemic stroke. Stroke (2005) 36(7):1452-1456.
   PubMed Web of Science ®Google Scholar
• ALEXANDROV AV: Ultrasound identification and lysis of clots. Stroke (2004) 35(11 Suppl. 1):2722-2725.
   PubMed Web of Science ®Google Scholar
• LEE KH, CHO SJ, BYUN HS et al.: Triphasic perfusion computed tomography in acute middle cerebral artery stroke: a correlation with angiographic findings. Arch. Neurol. (2000) 57(7):990-999.
   PubMedGoogle Scholar
• FIEHLER J, KNUDSEN K, KUCINSKI T et al.: Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke (2004) 35(2):514-519.
   PubMed Web of Science ®Google Scholar
• KIDWELL CS, ALGER JR, SAVER JL: Beyond mismatch: evolving paradigms in imaging the ischaemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 34(11):2729-2735.
   PubMed Web of Science ®Google Scholar
• DEL ZOPPO GJ, HIGASHIDA RT, FURLAN AJ et al.: PROACT: a Phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke (1998) 29(1):4-11.
   PubMed Web of Science ®Google Scholar
• FURLAN A, HIGASHIDA R, WECHSLER L et al.: Intra-arterial prourokinase for acute ischaemic stroke. The PROACT II study: a randomised controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA (1999) 282(21):2003-2011.
   PubMed Web of Science ®Google Scholar
• BROTT TG, HALEY EC Jr, LEVY DE et al.: Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke (1992) 23(5):632-640.
   PubMed Web of Science ®Google Scholar
• SUAREZ JI, SUNSHINE JL, TARR R et al.: Predictors of clinical improvement, angiographic recanalization, and intracranial haemorrhage after intra-arterial thrombolysis for acute ischaemic stroke. Stroke (1999) 30(10):2094-2100.
   PubMed Web of Science ®Google Scholar
• BENDSZUS M, URBACH H, RIES F, SOLYMOSI L: Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology (1998) 40(1):54-58.
   PubMed Web of Science ®Google Scholar
• CHESEBRO JH, KNATTERUD G, ROBERTS R et al.: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 76(1):142-154.
   PubMed Web of Science ®Google Scholar
• LEE DH, JO KD, KIM HG et al.: Local intraarterial urokinase thrombolysis of acute ischaemic stroke with or without intravenous abciximab: a pilot study. J. Vasc. Interv. Radiol. (2002) 13(8):769-774.
   PubMed Web of Science ®Google Scholar
• QURESHI AI, HARRIS-LANE P, KIRMANI JF et al.: Intra-arterial reteplase and intravenous abciximab in patients with acute ischaemic stroke: an open-label, dose-ranging, Phase I study. Neurosurgery (2006) 59(4):789-796; discussion 796-787.
   PubMed Web of Science ®Google Scholar
• MANGIAFICO S, CELLERINI M, NENCINI P, GENSINI G, INZITARI D: Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am. J. Neuroradiol. (2005) 26(10):2595-2601.
   PubMed Web of Science ®Google Scholar
• MOLINA CA, SAVER JL: Extending reperfusion therapy for acute ischaemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke (2005) 36(10):2311-2320.
   PubMed Web of Science ®Google Scholar
• SUAREZ JI, ZAIDAT OO, SUNSHINE JL et al.: Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischaemic strokes. Neurosurgery (2002) 50(2):251-259; discussion 259-260.
   PubMed Web of Science ®Google Scholar
• LEE KY, KIM DI, KIM SH et al.: Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischaemic stroke. AJNR Am. J. Neuroradiol. (2004) 25(9):1470-1475.
   PubMed Web of Science ®Google Scholar
• KIM DJ, KIM DI, KIM SH et al.: Rescue localised intra-arterial thrombolysis for hyperacute MCA ischaemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology (2005) 47(8):616-621.
   PubMed Web of Science ®Google Scholar
• ZAIDAT OO, SUAREZ JI, SANTILLAN C et al.: Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke (2002) 33(7):1821-1826.
   PubMed Web of Science ®Google Scholar
• SUGG RM, NOSER EA, SHALTONI HM et al.: Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischaemic stroke. AJNR Am. J. Neuroradiol. (2006) 27(4):769-773.
   PubMed Web of Science ®Google Scholar
• MAHON BR, NESBIT GM, BARNWELL SL et al.: North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am. J. Neuroradiol. (2003) 24(3):534-538.
   PubMed Web of Science ®Google Scholar
• BLINC A, FRANCIS CW, TRUDNOWSKI JL, CARSTENSEN EL: Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood (1993) 81(10):2636-2643.
   PubMed Web of Science ®Google Scholar
• ALEXANDROV AV, MOLINA CA, GROTTA JC et al.: Ultrasound-enhanced systemic thrombolysis for acute ischaemic stroke. N. Engl. J. Med. (2004) 351(21):2170-2178.
   PubMed Web of Science ®Google Scholar
• ALEXANDROV AV, DEMCHUK AM, FELBERG RA et al.: High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke (2000) 31(3):610-614.
   PubMed Web of Science ®Google Scholar
• DAFFERTSHOFER M, HENNERICI M: Ultrasound in the treatment of ischaemic stroke. Lancet Neurol. (2003) 2(5):283-290.
   PubMed Web of Science ®Google Scholar
• MITKA M: Researchers focus on improving treatments for acute ischaemic stroke. JAMA (2006) 295(14):1629-1631.
   PubMed Web of Science ®Google Scholar
• NORDT TK, MOSER M, KOHLER B et al.: Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction. Thromb. Haemost. (1998) 80(6):881-886.
   PubMed Web of Science ®Google Scholar
• MOSER M, NORDT T, PETER K et al.: Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase. Circulation (1999) 100(18):1858-1864.
   PubMed Web of Science ®Google Scholar
• QURESHI AI, SIDDIQUI AM, KIM SH et al.: Reocclusion of recanalised arteries during intra-arterial thrombolysis for acute ischaemic stroke. AJNR Am. J. Neuroradiol. (2004) 25(2):322-328.
   PubMed Web of Science ®Google Scholar
• JANG IK, GOLD HK, ZISKIND AA et al.: Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation (1990) 81(1):219-225.
   PubMed Web of Science ®Google Scholar
• BENEDICT CR, REFINO CJ, KEYT BA et al.: New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. Circulation (1995) 92(10):3032-3040.
   PubMed Web of Science ®Google Scholar
• FITZGERALD DJ, WRIGHT F, FITZGERALD GA: Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo. Circ. Res. (1989) 65(1):83-94.
   PubMed Web of Science ®Google Scholar
• MARDER VJ, CHUTE DJ, STARKMAN S et al.: Analysis of thrombi retrieved from cerebral arteries of patients with acute ischaemic stroke. Stroke (2006) 37(8):2086-2093.
   PubMed Web of Science ®Google Scholar
• HIGASHIDA RT: Recent advances in the interventional treatment of acute ischaemic stroke. Cerebrovasc. Dis. (Basel, Switzerland) (2005) 20(Suppl. 2):140-147.
   PubMedGoogle Scholar
• KATZ JM, GOBIN YP: Merci Retriever in acute stroke treatment. Expert Rev. Med. Dev. (2006) 3(3):273-280.
   PubMed Web of Science ®Google Scholar
• KATZ JM, GOBIN YP, SEGAL AZ, RIINA HA: Mechanical embolectomy. Neurosurg. Clin. North Am. (2005) 16(3):463-474, v.
   PubMed Web of Science ®Google Scholar
• SMITH WS, SUNG G, STARKMAN S et al.: Safety and efficacy of mechanical embolectomy in acute ischaemic stroke: results of the MERCI trial. Stroke (2005) 36(7):1432-1438.
   PubMed Web of Science ®Google Scholar
• SMITH WS: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischaemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischaemia (MERCI) trial, Part I. AJNR Am. J. Neuroradiol (2006) 27(6):1177-1182.
   PubMed Web of Science ®Google Scholar
• GOBIN YP, STARKMAN S, DUCKWILER GR et al.: MERCI 1: a Phase I study of mechanical embolus removal in cerebral ischaemia. Stroke (2004) 35(12):2848-2854.
   PubMed Web of Science ®Google Scholar
• BECKER KJ, BROTT TG: Approval of the MERCI clot retriever: a critical view. Stroke (2005) 36(2):400-403.
   PubMed Web of Science ®Google Scholar
• DI CARLO A, LAMASSA M, PRACUCCI G et al.: Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: a European perspective. European BIOMED Study of Stroke Care Group. Stroke (1999) 30(11):2313-2319.
   PubMed Web of Science ®Google Scholar
• SYLAJA PN, COTE R, BUCHAN AM, HILL MD: Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J. Neurol. Neurosurg. Psychiatry (2006) 77(7):826-829.
   PubMed Web of Science ®Google Scholar
• ENGELTER ST, BONATI LH, LYRER PA: Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age – a systematic review across cohort studies. Age Ageing (2006) 35(6):572-580.
   PubMed Web of Science ®Google Scholar
• ENGELTER ST, REICHHART M, SEKORANJA L et al.: Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology (2005) 65(11):1795-1798.
   PubMed Web of Science ®Google Scholar
• KERIS V, RUDNICKA S, VORONA V et al.: Combined intraarterial/intravenous thrombolysis for acute ischaemic stroke. AJNR Am. J. Neuroradiol. (2001) 22(2):352-358.
   PubMed Web of Science ®Google Scholar
• BARBER PA, DEMCHUK AM, ZHANG J, BUCHAN AM: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet (2000) 355(9216):1670-1674.
   PubMed Web of Science ®Google Scholar
• PEXMAN JH, BARBER PA, HILL MD et al.: Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am. J. Neuroradiol. (2001) 22(8):1534-1542.
   PubMed Web of Science ®Google Scholar
• HILL MD, ROWLEY HA, ADLER F et al.: Selection of acute ischaemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke (2003) 34(8):1925-1931.
   PubMed Web of Science ®Google Scholar
• HILL MD, DEMCHUK AM, TOMSICK TA, PALESCH YY, BRODERICK JP: Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am. J. Neuroradiol. (2006) 27(8):1612-1616.
   PubMed Web of Science ®Google Scholar
• COUTTS SB, DEMCHUK AM, BARBER PA et al.: Interobserver variation of ASPECTS in real time. Stroke (2004) 35(5):E103-E105.
   Google Scholar
• COUTTS SB, LEV MH, ELIASZIW M et al.: ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke (2004) 35(11):2472-2476.
   PubMed Web of Science ®Google Scholar
• DEMCHUK AM, HILL MD, BARBER PA et al.: Importance of early ischaemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke (2005) 36(10):2110-2115.
   PubMed Web of Science ®Google Scholar
• WEIR NU, PEXMAN JH, HILL MD, BUCHAN AM: How well does ASPECTS predict the outcome of acute stroke treated with IV tPA? Neurology (2006) 67(3):516-518.
   PubMed Web of Science ®Google Scholar
• GUADAGNO JV, WARBURTON EA, AIGBIRHIO FI et al.: Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study. J. Cereb. Blood Flow Metab. (2004) 24(11):1249-1254.
   PubMed Web of Science ®Google Scholar
• ALBERS GW, THIJS VN, WECHSLER L et al.: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann. Neurol. (2006) 60(5):508-517.
   PubMed Web of Science ®Google Scholar
• HACKE W, ALBERS G, AL-RAWI Y et al.: The Desmoteplase in Acute Ischaemic Stroke Trial (DIAS): a Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke (2005) 36(1):66-73.
   PubMed Web of Science ®Google Scholar
• FURLAN AJ, EYDING D, ALBERS GW et al.: Dose Escalation of Desmoteplase for Acute Ischaemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke (2006) 37(5):1227-1231.
   PubMed Web of Science ®Google Scholar
• BARBER PA, DEMCHUK AM, HUDON ME et al.: Hyperdense sylvian fissure MCA “dot” sign: a CT marker of acute ischaemia. Stroke (2001) 32(1):84-88.
   PubMed Web of Science ®Google Scholar
• FLACKE S, URBACH H, KELLER E et al.: Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology (2000) 215(2):476-482.
   PubMed Web of Science ®Google Scholar
• KIM EY, LEE SK, KIM DJ et al.: Detection of thrombus in acute ischaemic stroke: value of thin-section noncontrast-computed tomography. Stroke (2005) 36(12):2745-2747.
   PubMed Web of Science ®Google Scholar
• SEKORANJA L, LOULIDI J, YILMAZ H et al.: Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischaemic stroke: a transcranial color-coded duplex sonography–guided pilot study. Stroke (2006) 37(7):1805-1809.
   PubMed Web of Science ®Google Scholar
• SAQQUR M, SHUAIB A, ALEXANDROV AV et al.: Derivation of transcranial Doppler criteria for rescue intra-arterial thrombolysis: multicenter experience from the Interventional Management of Stroke study. Stroke (2005) 36(4):865-868.
   PubMed Web of Science ®Google Scholar
• JOSEPHSON SA, DILLON WP, SMITH WS: Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology (2005) 64(10):1805-1806.
   PubMed Web of Science ®Google Scholar
• WINTERMARK M, FIEBACH J: Iodinated and gadolinium contrast media in computed tomography (CT) and magnetic resonance (MR) stroke imaging. Curr. Med. Chem. (2006) 13(22):2717-2723.
   PubMed Web of Science ®Google Scholar
• TOMANEK AI, COUTTS SB, DEMCHUK AM et al.: MR angiography compared to conventional selective angiography in acute stroke. Can. J. Neurol. Sci. (2006) 33(1):58-62.
   PubMed Web of Science ®Google Scholar
• YANG JJ, HILL MD, MORRISH WF et al.: Comparison of pre- and postcontrast 3D time-of-flight MR angiography for the evaluation of distal intracranial branch occlusions in acute ischaemic stroke. AJNR Am. J. Neuroradiol. (2002) 23(4):557-567.
   PubMed Web of Science ®Google Scholar
• SHALTONI HM, ALBRIGHT KC, GONZALES NR et al.: Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischaemic stroke? Stroke (2007) 38(1):80-84.
   PubMed Web of Science ®Google Scholar
• LIBERATORE GT, SAMSON A, BLADIN C, SCHLEUNING WD, MEDCALF RL: Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke (2003) 34(2):537-543.
   PubMed Web of Science ®Google Scholar
• DAVYDOV L, CHENG JW: Tenecteplase: a review. Clin. Ther. (2001) 23(7):982-997; discussion 981.
   PubMed Web of Science ®Google Scholar